Spero Therapeutics 10K 2021 Annual report | SPRO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absence, absent, advocacy, alveolar, AMR, analogue, Analyst, anatomical, Andersen, anticompetitive, assemble, bacterium, Bartlett, Beecham, Belgium, biomarker, BlackRock, blanket, Brentford, brochure, burn, Canadian, Carlo, CDPA, Celator, cellular, Centocor, Cerevel, CMC, column, Commerce, conflict, constitutionality, Cornerstone, Counsel, CPRA, customary, Dame, decade, deficiency, Deputy, DISARM, dismissed, Duke, EAPO, earthquake, East, ELF, encompassing, Enzyvant, epithelial, Escherichia, ESRD, evergreen, evidentiary, expeditiously, explaining, extrapolate, fate, forty, French, gathered, Great, Hainan, Hard, harmonized, HB, HCR, hybrid, Idec, ILD, ImClone, Importantly, impossible, impute, imputed, infused, infusion, inlicensed, intrapulmonary, InVivo, Island, ITT, Jackson, Jazz, Johnson, Joseph, junk, Kathleen, Kennedy, Kremlin, Lancet, Larimar, LECG, legislature, licensure, lien, lift, lifted, linked, Lipopolysaccharide, LO, lognormal, Los, mail, Malaysian, marketplace, martial, Mayne, Mayor, median, Meridian, MHRA, Middlesex, midpoint, Millendo, Monte, Moscow, multinational, mutual, NaNne, nationwide, NHP, nosocomial, Notre, NY, official, omicron, omission, output, PASTEUR, pertinent, PHI, Philadelphia, piggyback, Pioneering, pledged, preapproval, premarket, Protara, Putnam, ratio, reclassification, recurrence, recurrent, registry, regular, repay, repayment, Republic, resale, Resiliency, RIS, Road, Roadmap, Rospatent, RTF, rulemaking, runway, Russian, Sanofi, Satyavrat, Scott, secondary, shareholder, shipment, shipping, Shukla, signaled, Simmering, Simulation, SmithKline, Socialist, stalled, Stanford, stoppage, sweeping, systematic, Tamara, thereon, tissue, Transkaryotic, Tregoning, twelfth, UI, uncommon, unconstrained, unfriendly, unlawfully, unsecured, Upsurging, uptake, VAP, variant, Virginia, West, Winthrop, wound, YM, Ziopharm

Removed: allergic, attributed, Aviragen, avoiding, ban, Biota, biothreat, catheter, climbing, compare, concept, confronted, consolidating, contributor, crucial, die, differentiate, dosed, driver, Duin, emphasizing, empirically, enabling, endemicity, equally, experiencing, favorably, feasibility, figure, flat, granule, hepatic, injectable, inserted, insertion, IPO, IQVIA, Iterum, leaflet, marginal, microbe, Northern, obviate, offsetting, oy, packaged, peripherally, perpetual, pharmacologic, PICC, pneumonic, Problem, proof, reimbursable, reliably, remained, responsive, Restoration, revaluation, revalue, shift, shortening, soil, stepdown, sulopenem, supervising, survey, taxation, TCJA, temporary, top, transmission, treated, unallocated, van, water, XDR

Spero Therapeutics (SPRO) 10-K2021 FY Annual report

Content analysis